Beit Shulamit / The Dr. Shulamit Katzman Cancer Center
Unique architectural design by world-renowned Ron Arad / building materials and concept are unlike anything built in Israel and are of a considerably higher standard.
Establishing a comprehensive and advanced Cancer Center is our vision and dream coming true. Under one roof and in accordance with the highest international standards, Beit Shulamit will offer modern treatment of malignant diseases that require multi-disciplinary collaboration including surgeons, oncologists, imaging experts, interventional radiologists, experts in the field of pain management, palliative care specialists – together with other health professionals; psychologists, nurses and social workers. The center's emphasis will be on diagnosing & treating malignant diseases while focusing on the healthy aspects and wellbeing of patients and their families. Beit Shulamit is affiliated academically with the Technion Institute of Technology and will be the only such all-inclusive center in the Northeast, raising the level of Emek Medical Center and helping to strengthen Northern Israel.
Emek Medical Center
Located in Afula in the Lower Galilee region, Emek, a 588 bed facility, serves more than 600,000 residents throughout Northeastern Israel who are for the most part in the mid to low socio-economic range. The region is equally divided (50/50) between Jews and Arabs and Emek's multi-ethnic staff and highest multi-cultural patient satisfaction ratings attest to the fact that Jewish/Arab collaboration is a normal element of daily regional life. As the region's largest employer, Emek prides itself on its highly regarded staff of 2,600 employees, 34 medical departments, 98 Outpatient Clinics, laboratories, and educational opportunities. As the medical needs of the population have increased, Emek has routinely offered exceptional care to each of their patients and is regularly voted a leader in patient satisfaction surveys.
This iconic facility (already attracting national and international interest) will change the face of healthcare for northeastern Israel as it will usher in an era of near-to-home cancer treatment and care unavailable until now to more than a half million residents. The Beit Shulamit Cancer Center will provide a welcoming close-to-nature haven for consultations, testing, diagnosis, state-of-the-art radiation therapy, complimentary therapies, ambulatory chemo-therapy, adult and pediatric inpatient departments, a unique well-being center and will house an exceptional Cancer Research Center.
Currently, about 4,000 patients with malignant diseases are diagnosed and operated on annually. Another 10,000 chemotherapy treatments are administered each year. The cancer patients of our region who also require radiation therapy are forced to travel distances from 50 – 100 km to receive radiation treatments in Rambam Hospital in Haifa. Our population is in the medium to low socio-economic level and traveling such distances is particularly difficult and even prohibitive for them. Because there is no such Cancer Center facility in northeastern Israel, many of these suffering people are required to use public transportation and spend hours each day on the road to receive a few minutes of radiation therapy! Negative resulting impact on medical services for our regional population base:
- 7 – 8 week wait for radiation, prior to surgery or chemotherapy
- Need to travel long distances each day
- Minority of referrals for palliative care radiation
- Inability to plan split daily treatment; chemo & radiation
Being the primary healthcare provider for 600,000 residents of our northeastern region, EMC is naturally positioned to deliver more comprehensive lifesaving services. Our regional population depends upon EMC to treat and save them.
Our peripheral population needs and prefers to be treated nearer to their homes, especially when dealing with serious illnesses that require treatments lasting weeks, months and even years. These people need and deserve to be close to family and friends in a familiar environment where critical emotional support is there for them. Our children have a critical need to be treated near home so as to maintain contact with their friends and schools. The establishment of the Dr. Shulamit Katzman Cancer Center for the people in our peripheral region will answer these needs, like those people living in Tel Aviv, Jerusalem and Haifa are already accustomed to.
Beit Shulamit is a ₪311,000,000 / $94,000,000 project ($ = ₪3.33)
Beit Shulamit, one of the most advanced cancer centers in Israel, is being erected on the campus of Emek Medical Center in Afula, on an area of 11,000 square meters, and will house under a single roof all that is necessary for the diagnosis and treatment of cancer. Beit Shulamit will employ the finest physicians and will be equipped with the most up-to-date instrumentation for the purpose of offering high-quality medical services to the population in the northern periphery of Israel.
Adult clinics will include a hematology unit (leukemia, lymphoma etc.) and an oncology unit (colon cancer, lung cancer etc. The clinics are expected to be visited by 10,000 patients every year.
The day hospital department is expected to administer close to 20,000 chemotherapy treatments a year to oncology and hematology patients. The department will comprise multiple chemotherapy stations, specially designed to offer a wide-range of options, starting in treatment in a private room, through to a communal treatment space that allows social interaction. All stations will have a view to the open grounds and nature.
Oncology-Hematology Children's Center
The Oncology-Hematology Center is expected to service close to 4,000 children every year. The Center will offer diagnosis, ambulatory treatment and day treatment for children. The Center will contain separate areas for oncology treatments and hematology treatments, as well as several isolation rooms. The design of the Center will be child-friendly and appropriate and will include a separate entrance and a playground.
The Hospitalization Ward will contain 36 inpatient beds in rooms that will be specially designed to allow optimal privacy for each patient alongside a spectacular view of the Jezreel Valley. The Ward will be located on the third floor, with covered balconies offering additional space for the patients and their family members.
The radiation institute is expected to service close to 1,500 patients every year, with several treatments per patient. The institute is expected to be one of the most active departments of the Cancer Center. The institute will contain two accelerators as well as infrastructure for a third accelerator. It will be located on the ground floor of Beit Shulamit and, unlike other radiation institutes, will have a view to the valley.
The mental strength of the patient and his or her family are crucial to fighting cancer. Beit Shulamit will make available to patients and their families a variety of complementary therapy and activities, aiming to provide some relief, such as shiatzu, reflexology, yoga, and art and music therapy. The Center will also offer patients a hairdresser, a library and a therapeutic garden. The Center will service thousands of patients and family members every year.
Auditorium & Main Entryway Lobby / Special Naming Opportunity
Anyone entering Beit Shulamit will first pass directly through the gracious auditorium lobby on their way to reception. The multifunctional auditorium will have 80 permanent comfortable seats arranged on a terraced floor for unobstructed viewing, an elegant stage and podium and state-of-the-art audio visual equipment. The overall design will be inviting, pleasing to the eye and a unique compliment to Beit Shulamit, allowing for conferences and special activities. It is within the welcoming lobby that the naming signage will appear as it will be among the very first sights that greet all visitors. The exact placement, design and wording will be agreed upon with the donor(s), Mr. Katzman, Clalit and Emek.
Research Institute / Special Naming Opportunity
Beit Shulamit will operate one of the world's most advanced centers for cancer research, under the academic wings of the Technion. The academic committee of the Center will be headed by Prof. Aharon Chakhnover of the Technion, winner of the Nobel Prize in Chemistry 2014. The Research Institute will allow the combination of basic research and clinical research for physicians working at Beit Shulamit who seek to combine the practice and research of medicine, and for researchers of the Technion and from around the globe.
Naming opportunities for this unique institute, laboratories and facilities will be discussed upon request.
We look forward to your questions, requests for more information and your participation in this iconic project. Thank you!